DOCU vs OGEN · P/E 15, rev $2.98B vs rev $37.7K
DocuSign Inc (DOCU) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the DOCU and OGEN stock pages for the full models.
Not investment advice.